Half a century of European pharmaceutical legislation

Patients require quick access to safe, affordable, effective and good quality medicines. We now celebrate fifty years of European pharmaceutical legislation aimed at therapeutic innovation.
This legislation provides adequate protection of clinical trial subjects, efficient control of products before and during marketing and dissemination of objective information for a more rational use. It also provides incentives for the development of orphan drugs for rare diseases and of specific medicines for children. On 28 September 2015 the European Commission organised the conference ‘50 Years of EU Pharma: achievements and future perspectives' (Health-EU newsletter, 25 September 2015).
Click here for the focus article of the Health-EU newsletter.
Click here for more information about the conference on '50 Years of EU Pharma legislation, including the video recording.
Click here for more information about the NVC E-Course Pharmaceutical Packaging.

If you have any questions about this subject, please contact us: info@nvc.nl, +31-(0)182-512411. This item is also included in our monthly overview, the NVC Members-only Update.